BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 30522515)

  • 21. Systemic lupus erythematous increased lung cancer risk: Evidence from a meta-analysis.
    Wu Y; Hou Q
    J Cancer Res Ther; 2016; 12(2):721-4. PubMed ID: 27461640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fracture risk and bone mineral density levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis.
    Wang X; Yan S; Liu C; Xu Y; Wan L; Wang Y; Gao W; Meng S; Liu Y; Liu R; Xu D
    Osteoporos Int; 2016 Apr; 27(4):1413-1423. PubMed ID: 26753541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.
    Dreyer L; Faurschou M; Mogensen M; Jacobsen S
    Arthritis Rheum; 2011 Oct; 63(10):3032-7. PubMed ID: 21953088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between systemic lupus erythematosus and thyroid dysfunction: a meta-analysis.
    Luo W; Mao P; Zhang L; Yang Z
    Lupus; 2018 Nov; 27(13):2120-2128. PubMed ID: 30376437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hodgkin's lymphoma in systemic lupus erythematosus.
    Bernatsky S; Ramsey-Goldman R; Isenberg D; Rahman A; Dooley MA; Sibley J; Boivin JF; Joseph L; Armitage J; Zoma A; Clarke A
    Rheumatology (Oxford); 2007 May; 46(5):830-2. PubMed ID: 17255135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic lupus erythematosus and Hodgkin's lymphoma.
    Bhalla R; Ajmani HS; Kim WW; Swedler WI; Lazarevic MB; Skosey JL
    J Rheumatol; 1993 Aug; 20(8):1316-20. PubMed ID: 8230011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FCGR3B copy number loss rather than gain is a risk factor for systemic lupus erythematous and lupus nephritis: a meta-analysis.
    Yuan J; Zhao D; Wu L; Xu X; Pang Y; Zhang J; Ma Y; Liu J; Wang J
    Int J Rheum Dis; 2015 May; 18(4):392-7. PubMed ID: 24673810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic lupus erythematosus and the risk of malignancy.
    Cibere J; Sibley J; Haga M
    Lupus; 2001; 10(6):394-400. PubMed ID: 11434573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic lupus and malignancies.
    Bernatsky S; Kale M; Ramsey-Goldman R; Gordon C; Clarke AE
    Curr Opin Rheumatol; 2012 Mar; 24(2):177-81. PubMed ID: 22227880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignancy in Systemic Lupus Erythematosus (SLE) Patients.
    Cader RA; Mei Yee AK; Yassin A; Ahmad I; Haron SN
    Asian Pac J Cancer Prev; 2018 Dec; 19(12):3551-3555. PubMed ID: 30583682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum Adiponectin Levels in Patients With Systemic Lupus Erythematosus: A Meta-analysis.
    Dini AA; Wang P; Ye DQ
    J Clin Rheumatol; 2017 Oct; 23(7):361-367. PubMed ID: 28937471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review.
    Sultan SM; Ioannou Y; Isenberg DA
    Rheumatology (Oxford); 2000 Oct; 39(10):1147-52. PubMed ID: 11035137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies.
    Yurkovich M; Vostretsova K; Chen W; AviƱa-Zubieta JA
    Arthritis Care Res (Hoboken); 2014 Apr; 66(4):608-16. PubMed ID: 24106157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased incidence of cancer in systemic lupus erythematosus: a Finnish cohort study with more than 25 years of follow-up.
    Tallbacka KR; Pettersson T; Pukkala E
    Scand J Rheumatol; 2018 Nov; 47(6):461-464. PubMed ID: 29318934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of toxic epidermal necrolysis-like skin lesions with systemic lupus erythematosus and review of the literature.
    Yildirim Cetin G; Sayar H; Ozkan F; Kurtulus S; Kesici F; Sayarlioglu M
    Lupus; 2013 Jul; 22(8):839-46. PubMed ID: 23761100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis of systemic lupus erythematosus and the risk of cervical neoplasia.
    Liu H; Ding Q; Yang K; Zhang T; Li G; Wu G
    Rheumatology (Oxford); 2011 Feb; 50(2):343-8. PubMed ID: 20929972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between systemic lupus erythematosus and risk of cervical atypia: A meta-analysis.
    Chen Y; Wu X; Liu L
    Lupus; 2021 Nov; 30(13):2075-2088. PubMed ID: 34715754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignancies in systemic lupus erythematosus: a 2015 update.
    Goobie GC; Bernatsky S; Ramsey-Goldman R; Clarke AE
    Curr Opin Rheumatol; 2015 Sep; 27(5):454-60. PubMed ID: 26125105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and risk of metabolic syndrome in patients with systemic lupus erythematosus: A meta-analysis.
    Sun C; Qin W; Zhang YH; Wu Y; Li Q; Liu M; He CD
    Int J Rheum Dis; 2017 Aug; 20(8):917-928. PubMed ID: 28851080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis.
    Johnson DK; Reynolds KM; Poole BD; Montierth MD; Todd VM; Barnado A; Davis MF
    PLoS One; 2021; 16(1):e0243150. PubMed ID: 33481783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.